HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

Radiotherapy and Oncology

Volumn 113, Issue 3, 2014, Pages 317-323

  Lohaus, Fabian ^a,b,c   Linge, Annett ^a,b,c   Tinhofer, Inge ^a,d   Budach, Volker ^a,d   Gkika, Eleni ^a,e   Stuschke, Martin ^a,e   Balermpas, Panagiotis ^f   Rödel, Claus ^a,f   Avlar, Melanie ^a,f   Grosu, Anca Ligia ^a,g   Abdollahi, Amir ^a,h   Debus, Jürgen ^a,h,i   Bayer, Christine ^a   Belka, Claus ^a,j   Pigorsch, Steffi ^a,k   Combs, Stephanie E ^a,k   Mönnich, David ^b   Zips, Daniel ^b   Von Neubeck, Cläre ^a,c   Baretton, Gustavo B ^a,l,m   Löck, Steffen ^c   Thames, Howard D ⁿ   Krause, Mechthild ^a,b,c,n   Baumann, Michael ^a,b,c,n   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^e GOETHE UNIVERSITY   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ UNIVERSITY OF MUNICH   (Germany)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^l DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^m INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

ⁿ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

DKTK ROG; HNSCC; HPV; p16; p53; Postoperative radiochemotherapy

Indexed keywords

CISPLATIN; PROTEIN P16; PROTEIN P53; VIRUS DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CONTROL; CANCER PROGNOSIS; CHEMORADIOTHERAPY; DISTANT METASTASIS; FEMALE; GERMANY; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTICENTER STUDY; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; GENETICS; HEAD AND NECK NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84915817332     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.11.011     Document Type: Article

References (43)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. C.R. Leemans, B.J. Braakhuis, and R.H. Brakenhoff The molecular biology of head and neck cancer Nat Rev Cancer 11 2011 9 22
3. A.K. Chaturvedi, W.F. Anderson, and J. Lortet-Tieulent Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers J Clin Oncol 31 2013 4550 4559
4. E.M. Sturgis, and P.M. Cinciripini Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110 2007 1429 1435
5. S. Habbous, K.P. Chu, and X. Qiu The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre Cancer Epidemiol 37 2013 820 829
6. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952
7. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
8. R. Fietkau, C. Lautenschläger, and R. Sauer Postoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: results of the German phase III trial ARO 96-3 J Clin Oncol 24 2006 5507
9. J. Bernier, J.S. Cooper, and T.F. Pajak Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501) Head Neck 27 2005 843 850
10. C. Fakhry, and M.L. Gillison Clinical implications of human papillomavirus in head and neck cancers J Clin Oncol 24 2006 2606 2611
11. N. Agrawal, M.J. Frederick, and C.R. Pickering Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 Science 333 2011 1154 1157
12. H. Kawakami, I. Okamoto, and K. Terao Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma Cancer Med 2 2013 933 941
13. C.R. Salazar, R.V. Smith, and M.K. Garg Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment Head Neck Pathol 8 2014 77 87
14. C. Fakhry, W.H. Westra, and S. Li Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 2008 261 269
15. A.A. Ankola, R.V. Smith, R.D. Burk, M.B. Prystowsky, C. Sarta, and N.F. Schlecht Comorbidity, human papillomavirus infection and head and neck cancer survival in an ethnically diverse population Oral Oncol 49 2013 911 917
16. K.K. Ang, J. Harris, and R. Wheeler Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
17. S. Habbous, L.T. Harland, and A. La Delfa Comorbidity and prognosis in head and neck cancers: differences by subsite, stage, and human papillomavirus status Head Neck 36 2014 802 810
18. P. Lassen, J.G. Eriksen, S. Hamilton-Dutoit, T. Tramm, J. Alsner, and J. Overgaard Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck J Clin Oncol 27 2009 1992 1998
19. P. Lassen, J. Overgaard, and J.G. Eriksen Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials Radiother Oncol 108 2013 489 494
20. D. Rischin, R.J. Young, and R. Fisher Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial J Clin Oncol 28 2010 4142 4148
21. S. Marur, G. D'Souza, W.H. Westra, and A.A. Forastiere HPV-associated head and neck cancer: a virus-related cancer epidemic Lancet Oncol 11 2010 781 789
22. H. Mineta, A. Borg, M. Dictor, P. Wahlberg, J. Akervall, and J. Wennerberg P53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma Br J Cancer 78 1998 1084 1090
23. V. Bouvard, R. Baan, and K. Straif A review of human carcinogens - part B: biological agents Lancet Oncol 10 2009 321 322
24. M. Snietura, W. Piglowski, and M. Jaworska Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer Eur Arch Otorhinolaryngol 268 2011 721 726
25. E. Rios-Velazquez, F. Hoebers, and H.J.W.L. Aerts Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging Radiother Oncol 113 2014 317 323
26. A. Ivanova, B.F. Qaqish, and M.J. Schell Continuous toxicity monitoring in phase II trials in oncology Biometrics 61 2005 540 545
27. A.S. Garden, M.S. Kies, and W.H. Morrison Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century Radiat Oncol 8 2013 21
28. M.M. Rietbergen, S.R. Martens-deKemp, and E. Bloemena Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer Eur J Cancer 50 2014 765 773
29. T. Rieckmann, S. Tribius, and T.J. Grob HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity Radiother Oncol 107 2013 242 246
30. A.K. Gupta, J.H. Lee, and W.W. Wilke Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT Int J Radiat Oncol Biol Phys 74 2009 928 933
31. R.J. Kimple, M.A. Smith, and G.C. Blitzer Enhanced radiation sensitivity in HPV-positive head and neck cancer Cancer Res 73 2013 4791 4800
32. R. Dok, P. Kalev, and E.J. Van Limbergen P16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumors Cancer Res 74 2014 1739 1751
33. A.N. Snow, and J. Laudadio Human papillomavirus detection in head and neck squamous cell carcinomas Adv Anat Pathol 17 2010 394 403
34. W.H. Westra Detection of human papillomavirus (HPV) in clinical samples: Evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas Oral Oncol 50 2014 771 779
35. S.J. Smeets, A.T. Hesselink, and E.J. Speel A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen Int J Cancer 121 2007 2465 2472
36. H. Mineta, T. Ogino, and H.M. Amano Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma Anticancer Res 18 1998 4765 4768
37. F. Bussu, M. Sali, and R. Gallus Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators - A pilot study Int J Radiat Oncol Biol Phys 89 2014 1115 1120
38. K. Nylander, E. Dabelsteen, and P.A. Hall The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck J Oral Pathol Med 29 2000 413 425
39. J.K. Field, D.A. Spandidos, A. Malliri, J.R. Gosney, M. Yiagnisis, and P.M. Stell Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck Br J Cancer 64 1991 573 577
40. J.K. Field, D.A. Spandidos, and P.M. Stell Overexpression of p53 gene in head-and-neck cancer, linked with heavy smoking and drinking Lancet 339 1992 502 503
41. R. Maestro, R. Dolcetti, and D. Gasparotto High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx Oncogene 7 1992 1159 1166
42. M. Scheffner, B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1990 1129 1136
43. B.A. Werness, A.J. Levine, and P.M. Howley Association of human papillomavirus types 16 and 18 E6 proteins with p53 Science 248 1990 76 79